Dunhill Financial’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$545 Hold
4
﹤0.01% 1121
2026
Q1
$583 Buy
4
+3
+300% +$419 ﹤0.01% 1082
2025
Q4
$156 Buy
+1
New +$157 ﹤0.01% 1200
2024
Q3
Sell
-630
Closed -$79.4K 968
2024
Q2
$79.4K Buy
+630
New +$98.7K 0.05% 114

Other funds holding RGEN

Dunhill Financial's RGEN Position: Q2 2026 in Review

Dunhill Financial held its Repligen (RGEN) position steady in Q2 2026 at 4 shares worth $545. The position accounts for ﹤0.01% of the portfolio, ranked #1121.

Dunhill Financial first reported a position in RGEN in Q2 2024 and has held it in 4 quarters since. The position peaked at $79.4K in Q2 2024. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Dunhill Financial held 4 shares of Repligen worth $545 as of Q2 2026.
  • Dunhill Financial left its Repligen share count unchanged in Q2 2026.
  • Repligen made up ﹤0.01% of Dunhill Financial's portfolio in Q2 2026, its #1121 holding.
  • Dunhill Financial first reported a position in Repligen in Q2 2024 and has held it in 4 quarters since.
  • Dunhill Financial's Repligen position peaked at $79.4K in Q2 2024.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.